Skip to main content
. 2015 Apr 15;4:179. doi: 10.1186/s40064-015-0941-7

Table 3.

Stratified analysis for the association between LAPTM4B polymorphism and cancer risk by tumor type

Type of tumor Num *2 vs *1 *1/2 vs *1/1 *2/2 vs *1/1 *1/2 + *2/2 vs *1/1 *2/2 vs *1/2 + *1/1
OR(95%CI) P(H) OR(95%CI) P(H) OR(95%CI) P(H) OR(95%CI) P(H) OR(95%CI) P(H)
Digestive system 8 1.444(1.313-1.588)** 0.011 1.557(1.365-1.777)** 0.034 1.873(1.460-2.402)** 0.082 1.594(1.404-1.809)** 0.009 1.499(1.179-1.906)** 0.204
Gastrointestinal 2 1.334(1.176-1.513)** 0.003 1.332(1.119-1.584)** 0.084 1.603(1.125-2.285)* 0.024 1.359(1.149-1.607)** 0.020 1.400(0.990-1.981) 0.069
Gland 6 1.603(1.387-1.853)** 0.687 1.929(1.573-2.364)** 0.615 2.186(1.539-3.104)** 0.524 1.976(1.625-2.403)** 0.677 1.597(1.144-2.228)* 0.462
Gynecological tumor 3 1.810(1.583-2.069)** 0.253 1.891(1.563-2.287)** 0.584 2.900(2.156-3.901)** 0.638 2.073(1.733-2.480)** 0.400 2.144(1.619-2.839)** 0.716
Breast cancer 2 1.413(1.222-1.635)** 0.058 1.488(1.227-1.806)** 0.187 1.959(1.338-2.868)** 0.075 1.549(1.286-1.865)** 0.101 1.640(1.132-2.376)* 0.116
Lung cancer 3 1.454(1.236-1.710)** 0.026 1.467(1.169-1.842)** 0.458 2.073(1.431-3.002)** 0.004 1.563(1.260-1.939)** 0.164 1.748(1.226-2.492)* 0.006
Others 2 1.309(1.060-1.615)* 0.007 1.063(0.797-1.416) 0.017 2.337(1.420-3.847)** 0.075 2.860(2.184-3.745)** <0.001 2.278(1.403-3.698)** 0.220

*P < 0.05, **P ≤ 0.001, Num: the number of studies, P (H): the P value for test of heterogeneity among studies, Digestive system; include references (Liu et al. 2007; Cheng et al. 2008; Sun et al. 2008; Wang and Zhang 2010; Qi 2010; Yang et al. 2012; Wang et al. 2012; Zhai et al. 2012), Gastrointestinal: include references (Liu et al. 2007; Cheng et al. 2008), Gland: include references (Sun et al. 2008; Wang and Zhang 2010; Qi 2010; Yang et al. 2012; Wang et al. 2012; Zhai et al. 2012), Gynecological tumor: include references (Meng et al. 2011; Xu et al. 2012; Meng et al. 2013), Breast cancer: include references (Fan et al. 2012; Li et al. 2012), Lung cancer: include references (Deng et al. 2005; Li et al. 2006; Tang et al. 2014), others: includes Lymphoma (Sun et al. 2007) and Nasopharyngeal carcinoma (Wang et al. 2013).